768 papers found
Refreshing results…
Table S3
Table S7
Figure S1
Figure S2
Table S1
A New Algorithm for Integrated Analysis of miRNA-mRNA Interactions Based on Individual Classification Reveals Insights into Bladder Cancer
TableS8
Table S2
Table S5
Table S4
Figure S4
Table S6
Use of [-2]proPSA and prostate health index (phi) to improve the diagnostic accuracy of prostate cancer compared to t-PSA and %f-PSA in young men (≤ 65 years old).
Comparison of p40 (ΔNp63) and p63 expression in prostate tissues - which one is the superior diagnostic marker for basal cells?
Abstract 3224: Metabolite profiling as tool for the identification of differentiating and prognostic markers of prostate carcinoma.
2054 Reducing Unnecessary Biopsies for Suspicion of Prostate Cancer: Extension and Validation of an Erspc Based Risk Calculator With Phi and Comparison With the Pcpt Risk Calculator Including %Free and -2propsa
2133 [-2]propsa and Prostate Health Index (Phi) Improve Detection of Prostate Cancer at Initial and Repeated Biopsies in Young Men (
209 Metabolite Profiling as Tool for the Identification of Differentiating and Prognostic Markers of Prostate Carcinoma
Use of microRNA signature to distinguish early from late biochemical failure in prostate cancer.
Artificial neural networks and prostate cancer—tools for diagnosis and management
Missing publications? Read more about our data sources.